Generics price fixing charges land pharma firms $447.2m penalty 05-Oct-2021 By Jenni Spinner The US Department of Justice reports three generic drug manufacturers have been socked with the hefty fine to resolve alleged False Claims Act violations
Taro recalls seizure medicine over suspension problems 24-Feb-2020 By Ben Hargreaves Taro instigates a voluntary recall of phenytoin oral suspension after two lots are found not to re-suspend when shaken.